Guidelines for Restarting Therapeutic Unfractionated Heparin After Neuraxial Anesthesia

Timing of UFH Restart

Therapeutic UFH (>15,000 U/24 h) should be restarted 1 hour after removal of the epidural or spinal catheter, provided adequate hemostasis has been achieved and at least 4 hours have elapsed since the initial neuraxial placement. 3
The first prophylactic UFH dose must not be given earlier than 1 hour after catheter placement. This prevents early bleeding while still offering thromboprophylaxis. 3
If a prophylactic UFH regimen is used, the next dose after catheter removal should be delayed until 6 hours post‑removal. 1
For continuous intravenous UFH infusion, wait 4 hours after catheter removal before restarting the infusion. 1

Confirm hemodynamic stability and absence of active bleeding at the surgical site before restarting UFH. Hemodynamic stability is a basic prerequisite; active bleeding is specifically highlighted in the Blood guideline. [2][4]
Perform a focused neurological examination 4 hours after catheter removal (including straight‑leg‑raise testing) to detect early signs of epidural hematoma. 1
Document complete resolution of motor block using the Bromage scale before catheter removal. 1
If any progressive neurological deficit appears, obtain an immediate MRI; epidural hematoma must be evacuated within 8–12 hours to avoid irreversible injury. 1

Traumatic (bloody) puncture: extend the interval before any UFH dose to 24 hours after the puncture, because vascular trauma markedly raises the risk of epidural hematoma. 1

Low‑risk hemorrhagic procedures (e.g., minor surgery): follow standard timing—therapeutic UFH can be restarted 1 hour after catheter removal. 1
High‑risk hemorrhagic procedures (major neurosurgery, cardiovascular surgery): postpone therapeutic UFH for 48–72 hours after catheter removal. 4
Intermediate‑high thromboembolic risk (e.g., recent portal vein thrombosis): adhere to the standard 1‑hour restart timing. 4
Low‑to‑moderate thromboembolic risk: consider delaying therapeutic UFH for 48–72 hours and use mechanical prophylaxis or a prophylactic UFH dose during that period. 4
Step‑wise dosing strategy for high‑risk bleeding: initiate a prophylactic UFH dose during the first 24–48 hours, then transition to therapeutic dosing once bleeding risk subsides. 4

Neurological monitoring: repeat a full neurological exam every 4 hours for the first 24 hours after UFH is restarted. 1
Coagulation monitoring: adjust the UFH infusion rate to keep the activated partial thromboplastin time (aPTT) within the therapeutic range according to local protocols (e.g., anti‑Xa activity 0.3–0.7 U/mL). 3
Platelet monitoring: if UFH therapy extends beyond 5 days, check platelet counts regularly to detect heparin‑induced thrombocytopenia. 5

Do not confuse the timing of catheter placement with the timing of catheter removal; the required intervals differ. 3
Avoid restarting therapeutic UFH too early after high‑risk hemorrhagic surgery; the bleeding risk may outweigh thrombotic risk during the first 48–72 hours. 4

Record the exact time of catheter/needle removal.
Document the 4‑hour post‑procedure neurological examination.
Note the specific anticoagulant, dose, and time of UFH restart.
Obtain informed consent that explicitly discusses the increased bleeding risk associated with UFH restart.